Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)

Clinical trial NCT02155647 · COMPLETED

Trial details

NCT number: NCT02155647
Sponsor: EMD Serono Research & Development Institute, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Merkel Cell

Start date: 2014-07-03
Primary completion: 2019-05-02
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.